Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$187.39 USD

187.39
517,794

+1.13 (0.61%)

Updated Sep 17, 2025 04:00 PM ET

After-Market: $187.54 +0.15 (0.08%) 6:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (33 out of 245)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Universal Health Services (UHS) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Universal Health Services (UHS) delivered earnings and revenue surprises of 17.42% and 2.99%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Universal Health to Report Q4 Earnings: What Do the Estimates Say?

by Zacks Equity Research

UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.

Zacks Equity Research

Gear Up for Universal Health Services (UHS) Q4 Earnings: Wall Street Estimates for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Universal Health Services (UHS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.

Zacks Equity Research

Community Health Systems (CYH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Community Health Systems (CYH) delivered earnings and revenue surprises of -940% and 3.32%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Tenet Healthcare (THC) Surpasses Q4 Earnings Estimates

by Zacks Equity Research

Tenet (THC) delivered earnings and revenue surprises of 17.41% and 1.75%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health

by Zacks Equity Research

HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health have been highlighted in this Industry Outlook article.

Kaibalya Pravo Dey headshot

Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar

by Kaibalya Pravo Dey

The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.

Zacks Equity Research

HCA Healthcare Pre-Q4 Earnings: Golden Opportunity or Fool's Gold?

by Zacks Equity Research

HCA's fourth-quarter results are expected to benefit from rising admissions and patient days. However, increasing expenses are a concern.

Kaibalya Pravo Dey headshot

Universal Health Stock Trading at Attractive Valuation: Time to Buy?

by Kaibalya Pravo Dey

With UHS stock trading at a discount, we examine its growth drivers and challenges to determine if it presents a strong investment opportunity for investors at this time.

Kaibalya Pravo Dey headshot

HCA Healthcare Stock Trades at Premium: Time to Buy or Hold?

by Kaibalya Pravo Dey

HCA's strong cash-generating abilities are expected to improve its financial position.

Zacks Equity Research

Here's Why Universal Health Services (UHS) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Community Health Drops 36.4% in 3 Months: Hold, Sell, or Buy the Dip?

by Zacks Equity Research

CYH's growth drivers remain robust and should help it recover from the short-term setbacks.

Zacks Equity Research

Universal Health Up 46% in a Year: Is it the Right Time to Invest?

by Zacks Equity Research

UHS gains from growing patient volumes and an extensive treatment network. However, an elevated expense level can pressure margins in the days ahead.

Zacks Equity Research

Acadia Healthcare Stock Closer to 52-Week Low: A Buying Opportunity?

by Zacks Equity Research

ACHC is facing significant challenges, including lower returns, rising costs and declining free cash flow.

Zacks Equity Research

Are Options Traders Betting on a Big Move in Universal Health Services (UHS) Stock?

by Zacks Equity Research

Investors need to pay close attention to Universal Health Services (UHS) stock based on the movements in the options market lately.

Zacks Equity Research

Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Zacks Industry Outlook HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems

by Zacks Equity Research

HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.

Zacks Equity Research

5 Hospital Stocks Set to Thrive Amid Robust Industry Trends

by Zacks Equity Research

The Zacks Medical-Hospital industry is likely to gain from rising patient admissions and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are poised to gain from these trends.

Debasmita Chatterjee headshot

Analyzing Universal Health's Q3 Earnings: To Buy or Keep Your Cool?

by Debasmita Chatterjee

UHS is well-poised to benefit from growing patient volumes and extensive treatment network, partly offset by elevated operating costs.

Zubia Masood headshot

Should You Buy, Hold or Sell HCA Healthcare Stock After Q3 Earnings?

by Zubia Masood

HCA is poised to benefit from volume growth and expansion initiatives.

Zacks Equity Research

Universal Health Q3 Earnings Miss on Elevated Operating Costs

by Zacks Equity Research

UHS' Q3 results suffer from rising operating costs in salaries, wages and benefits, and supplies, impacting profitability. Nevertheless, strong revenue growth and increased admissions partly offset the downside.

Zacks Equity Research

Compared to Estimates, Universal Health Services (UHS) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for Universal Health Services (UHS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Universal Health Services (UHS) Lags Q3 Earnings Estimates

by Zacks Equity Research

Universal Health Services (UHS) delivered earnings and revenue surprises of -1.07% and 1.42%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Are Investors Undervaluing Universal Health Services (UHS) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

by Zacks Equity Research

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.